Considering the dual function of TEV-ncRNAs in controlling PD-1/PD-L1 expression, future studies in the field of tumor therapy should aim to exploit their immunostimulatory potential while avoiding the immunosuppressive impacts of EVs. This evidence concerns the gene PDCD1 and neoplasm.